Sarah Ketterer - Causeway Capital Management Portfolio
| Period Date | Mar 31, 2025 | |
| Filing Date | May 14, 2025 | |
| Total Stocks | 90 | |
| Portfolio Value | $4.78B |
Causeway Capital Management Activity
| Date | Symbol | Type | Quantity |
|---|---|---|---|
Q1 2025Mar 31, 2025 | PHG Koninklijke Philips N.V. NY Reg | Sell | -35,038-2.2% |
Q1 2025Mar 31, 2025 | SMIN Ishares MSCI India Small Cap ET | Sell | -36,112-29.9% |
Q1 2025Mar 31, 2025 | NWG NatWest Group plc | Sell | -37,162-4.6% |
Q1 2025Mar 31, 2025 | ITUB Itau Unibanco Banco Holding SA | Sell - Position Exit | -43,222-100.0% |
Q1 2025Mar 31, 2025 | EFA iShares MSCI EAFE ETF | Sell | -46,583-87.9% |
Q1 2025Mar 31, 2025 | URTH iShares, Inc. iShares MSCI Worl | Sell - Position Exit | -51,466-100.0% |
Q1 2025Mar 31, 2025 | QFIN Qifu Technology, Inc | Sell | -70,202-5.1% |
Q1 2025Mar 31, 2025 | INDA Ishares MSCI India ETF | Sell | -87,422-37.9% |
Q1 2025Mar 31, 2025 | DGX Quest Diagnostics Incorporated | Sell | -184,081-60.5% |
Q1 2025Mar 31, 2025 | BA Boeing Company (The) | Sell - Position Exit | -302,750-100.0% |
Q1 2025Mar 31, 2025 | PDD PDD Holdings Inc. | Sell | -340,346-76.3% |
Q1 2025Mar 31, 2025 | MT Arcelor Mittal NY Registry Shar | Sell | -363,109-34.0% |
Q1 2025Mar 31, 2025 | RDY Dr. Reddy's Laboratories Ltd | Sell | -394,866-73.2% |
Q1 2025Mar 31, 2025 | CNXC Concentrix Corporation | Sell - Position Exit | -409,812-100.0% |
Q1 2025Mar 31, 2025 | SNX TD SYNNEX Corporation | Sell | -465,423-78.0% |
Q1 2025Mar 31, 2025 | FINV FinVolution Group | Sell | -518,351-18.5% |
Q1 2025Mar 31, 2025 | TAK Takeda Pharmaceutical Company L | Sell - Position Exit | -522,030-100.0% |
Q1 2025Mar 31, 2025 | VEA Vanguard FTSE Developed Markets | Sell | -860,458-67.9% |
Q1 2025Mar 31, 2025 | BTG B2Gold Corp | Sell | -966,813-91.1% |
Q1 2025Mar 31, 2025 | BCS Barclays PLC | Sell | -1,418,525-23.9% |
Q1 2025Mar 31, 2025 | BBD Banco Bradesco Sa | Sell | -32,714,894-90.1% |
Q4 2024Dec 31, 2024 | GOLD Barrick Gold Corporation | Buy - Position Entry | +11,112,293 |
Q4 2024Dec 31, 2024 | CP Canadian Pacific Kansas City Li | Buy | +6,687,770+76.5% |
Q4 2024Dec 31, 2024 | VEA Vanguard FTSE Developed Markets | Buy | +780,830+160.8% |
Q4 2024Dec 31, 2024 | MRK Merck & Company, Inc. | Buy - Position Entry | +584,473 |
Q4 2024Dec 31, 2024 | BCS Barclays PLC | Buy | +484,497+8.9% |
Q4 2024Dec 31, 2024 | SNN Smith & Nephew SNATS, Inc. | Buy - Position Entry | +480,888 |
Q4 2024Dec 31, 2024 | RDY Dr. Reddy's Laboratories Ltd | Buy | +431,444+400.0% |
Q4 2024Dec 31, 2024 | ALLY Ally Financial Inc. | Buy - Position Entry | +423,364 |
Q4 2024Dec 31, 2024 | ING ING Group, N.V. | Buy | +416,762+38.8% |